In 2021, the Australian Thyroid Foundation released analysis to show, well over 1 million Australian are living with an undiagnosed thyroid disorder, including thyroid cancer, lower IQs, lifelong disability, and a causal or possible contributory factor – in the development of other neurological disorders such as ADHD and autism. Some of the challenges for diagnosis and treatment can be addressed by producing material for health care practitioners during patient presentations.
‘Recent statistics show well over 1 million Australians are living with an undiagnosed thyroid disorder, awareness and testing can prevent unwarranted outcomes for mothers and their babies’ says ATF CEO Beverley Garside OAM
Australia has been labelled by the World Health Organisation (WHO) as being iodine deficient, and evidenced in research in 2005-06 by Westmead Hospital and Sydney University (see 1 below)
The World Health Organisation states iodine deficiency during pregnancy and early infancy –the first 1000 days of life when development of the human brain is so critical – is the commonest global cause of preventable intellectual disability (see 2 below)
Thyroid Disorders affect all Australians of all age groups and demographics. Awareness is the key to ensuring the public and healthcare professionals do not overlook a thyroid disorder which could be affecting health and wellbeing.
– 1 in 10 Australians will be affected by some form of thyroid disorder
– 7 of the 10 are women
– Over 1 million Australians are undiagnosed
– 60,000 Australians are diagnosed each year
– Thyroid Cancer is increasing, affecting younger Australians
– Iodine Deficiency & Thyroid Disorders affect pregnancy outcomes for women of childbearing years.
As a Not-For-Profit health charity, The Australian Thyroid Foundation Ltd (ATF) mission is to offer information, education, advocacy and support to members and their families, using services provided by ATF and raise much needed awareness throughout Australia about the consequences of thyroid disease and iodine deficiency and the benefits of achieving good thyroid health.
In recent years ATF has launched campaigns aimed at reaching a number of patient types requiring treatment for the thyroid gland and thyroid hormone production. These have created some level of awareness within the public and health care professionals (HCPs).
The Australian Thyroid Foundation has lodged a Pre-Budget Submission for the Federal Budget 2024-25 to counter increasing misinformation on social media creating dietary deficiencies such as an increasing number of young women, who are planning pregnancy or already pregnant opting for plant based milks such almond, soy or oat milk coffee as an alternative to standard cow’s milk, which is a source of iodine and alternate milks do not include.
Australian Health Journal spoke with endocrinologist, Adj. Prof. Duncan Topliss AM, a Medical Advisory Board Member at The Australian Thyroid Foundation Ltd, about issues raised in the submission.
References
1. Evidence for iodine deficiency in the Australian population was derived from a national study on Australian schoolchildren in 2003-2004 in which the ATF actively participated with a large group of Australian clinical researchers. The outcome was the implementation of the mandatory iodine fortification of all salt used in the baking of bread and bread products in Australia and New Zealand.
2. Multiple studies undertaken on pregnant women have revealed that iodine intake in at least 50% of pregnancies in Australia is deficient, despite the addition of iodised salt to bread, putting the next generation of Australian children at risk of neuro-developmental disorders and lower IQ.
You Might also like
- 
					
					AHJ S1E4: Augmented Reality Learning – Inside MSAugmented learning now has application seeing the changes in a patient’s brain with Multiple Sclerosis through MRI data. Australian Health Journal met the people behind the augmented reality visor technology that will soon be used to teach trainee doctors the transitional phases of MS. The technology has been developed by Novartis and in collaboration with the Sydney Neuroimaging Analysis Centre, located within the University of Sydney’s Brain and Mind Centre and Hatch Australia, a creative design team based in Sydney. To date the technology has been well received by neurology health care specialists attending conferences in Melbourne and in Berlin, Germany. We caught with a demo for all other healthcare professionals at the recent ARCS Conference. 
 Post Views:
 1,745
- 
					
					World-first clinical trial improves patient outcomes for kidney transplantsA world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant. Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins. 
- 
					
					Addressing Pharmacy challenges at home and abroadPaul Sinclair’s progression through the ranks of the International Pharmaceutical Federation (FIP) demonstrates the impact and influence he’s had in representing the pharmacy profession on a global scale. In this Australian Health Journal interview, Paul talks about the 4 themes in the upcoming FIP Congress in Brisbane this month. He also talks about the challenges facing pharmacy with remuneration, professional service delivery and the workforce coming out of the COVID era. 
 
		
		 
					
																 
					
																				
					